Hybrid Silica Technologies, Inc. (HST) develops nano-
structured silica materials, with a current emphasis on fluorescent core-shell nanoparticles (C•spec® particles)
for imaging, diagnostics, and sensing.
March 30, 2012 - HST’s latest product line: C•spec® NHS ester particles. HST is introducing a new series of NHS ester functionalized C•spec® products. C•spec® NHS ester particles are available in three different sizes and various emission wavelengths. Our customers have found that particle size is an important factor to optimize conjugate performance. C•spec® NHS ester particles are ideal for researchers to perform efficient labeling of protein, antibodies. Labeled proteins are ready in two hours using a simple protocol.
October 18, 2011 - Announcing HST’s latest product line: C•spec® particles conjugated to streptavidin. HST has been selling these products to early adopters, and based on their response and our own testing, we are now making the conjugates more widely available. Over the coming weeks, we will be introducing a series of new products that include a range of proteins labeled with C•spec® particles of different sizes and emission signatures.
May 04, 2011 - C dots give doctors eyes for cancer.
Please refer to the following article by Bob Hackett at
Cornell Daily Sun.
 |
Renal Clearance of C•spec® particles in Mice (March 12, 2009). Development of C•spec® particles capable of clearance from the body via the kidneys.
|
|
 |
A biocompatible and green material. HST's materials are based on amorphous silica, a highly versatile, thermally stable and "green" material.
|
 |
Please feel free to contact our sales and development team at mail@hybridsilica.com to specify your requirements for C•spec® particles or other hybrid silica materials.
|
 |
An advance look at a theoretical chart that we are working to put into practice by populating a data space with actual brightness and size measurements of C•spec®.
|
|
